Abstract
This pilot study explores the feasibility and preliminary efficacy of the Staying Safe Intervention, an innovative, strengths-based program to facilitate prevention of infection with the human immunodeficiency virus and with the hepatitis C virus among people who inject drugs (PWID). The authors explored changes in the intervention’s two primary endpoints: (a) frequency and amount of drug intake, and (b) frequency of risky injection practices. We also explored changes in hypothesized mediators of intervention efficacy: planning skills, motivation/self-efficacy to inject safely, skills to avoid PWID-associated stigma, social support, drug-related withdrawal symptoms, and injection network size and risk norms. A I-week, five- session intervention (10 hours total) was evaluated using a pre- versus 3-month posttest design. Fifty-one participants completed pre- and posttest assessments. Participants reported significant reductions in drug intake and injection-related risk behavior. Participants also reported significant increases in planning skills, motivation/self-efficacy, and stigma management strategies, while reducing their exposure to drug withdrawal episodes and risky injection networks.
Original language | English (US) |
---|---|
Pages (from-to) | 144-157 |
Number of pages | 14 |
Journal | AIDS Education and Prevention |
Volume | 26 |
Issue number | 2 |
State | Published - 2014 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Infectious Diseases
- Health(social science)
- Medicine(all)
Cite this
The staying safe intervention : Training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. / Mateu-Gelabert, Pedro; Viorst Gvvadz, Marya; Guarino, Honoria; Sandoval, Milagros; Cleland, Charles M.; Jordan, Ashly; Hagan, Holly; Lune, Howard; Friedman, Samuel R.
In: AIDS Education and Prevention, Vol. 26, No. 2, 2014, p. 144-157.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The staying safe intervention
T2 - Training people who inject drugs in strategies to avoid injection-related HCV and HIV infection
AU - Mateu-Gelabert, Pedro
AU - Viorst Gvvadz, Marya
AU - Guarino, Honoria
AU - Sandoval, Milagros
AU - Cleland, Charles M.
AU - Jordan, Ashly
AU - Hagan, Holly
AU - Lune, Howard
AU - Friedman, Samuel R.
PY - 2014
Y1 - 2014
N2 - This pilot study explores the feasibility and preliminary efficacy of the Staying Safe Intervention, an innovative, strengths-based program to facilitate prevention of infection with the human immunodeficiency virus and with the hepatitis C virus among people who inject drugs (PWID). The authors explored changes in the intervention’s two primary endpoints: (a) frequency and amount of drug intake, and (b) frequency of risky injection practices. We also explored changes in hypothesized mediators of intervention efficacy: planning skills, motivation/self-efficacy to inject safely, skills to avoid PWID-associated stigma, social support, drug-related withdrawal symptoms, and injection network size and risk norms. A I-week, five- session intervention (10 hours total) was evaluated using a pre- versus 3-month posttest design. Fifty-one participants completed pre- and posttest assessments. Participants reported significant reductions in drug intake and injection-related risk behavior. Participants also reported significant increases in planning skills, motivation/self-efficacy, and stigma management strategies, while reducing their exposure to drug withdrawal episodes and risky injection networks.
AB - This pilot study explores the feasibility and preliminary efficacy of the Staying Safe Intervention, an innovative, strengths-based program to facilitate prevention of infection with the human immunodeficiency virus and with the hepatitis C virus among people who inject drugs (PWID). The authors explored changes in the intervention’s two primary endpoints: (a) frequency and amount of drug intake, and (b) frequency of risky injection practices. We also explored changes in hypothesized mediators of intervention efficacy: planning skills, motivation/self-efficacy to inject safely, skills to avoid PWID-associated stigma, social support, drug-related withdrawal symptoms, and injection network size and risk norms. A I-week, five- session intervention (10 hours total) was evaluated using a pre- versus 3-month posttest design. Fifty-one participants completed pre- and posttest assessments. Participants reported significant reductions in drug intake and injection-related risk behavior. Participants also reported significant increases in planning skills, motivation/self-efficacy, and stigma management strategies, while reducing their exposure to drug withdrawal episodes and risky injection networks.
UR - http://www.scopus.com/inward/record.url?scp=84900561740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900561740&partnerID=8YFLogxK
M3 - Article
C2 - 24694328
AN - SCOPUS:84900561740
VL - 26
SP - 144
EP - 157
JO - AIDS Education and Prevention
JF - AIDS Education and Prevention
SN - 0899-9546
IS - 2
ER -